Alberto M. Martelli - Search Results

Year	Number of Results
2002	11
2003	7
2004	9
2005	12
2006	9
2007	9
2008	19
2009	11
2010	13
2011	10
2012	21
2013	7
2014	17
2015	15
2016	14
2017	11
2018	19
2019	12
2020	13
2021	6
2022	9
2023	2
2024	1

1

The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH.

Cervello M, Augello G, Cocco L, Ratti S, Follo MY, Martelli AM, Cusimano A, Montalto G, McCubrey JA. Cervello M, et al. Among authors: martelli am. Adv Biol Regul. 2024 Apr 23:101032. doi: 10.1016/j.jbior.2024.101032. Online ahead of print. Adv Biol Regul. 2024. PMID: 38693042

2

Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Martelli AM, Paganelli F, Truocchio S, Palumbo C, Chiarini F, McCubrey JA. Martelli AM, et al. Int J Mol Sci. 2023 Feb 3;24(3):2962. doi: 10.3390/ijms24032962. Int J Mol Sci. 2023. PMID: 36769284 Free PMC article. Review.

3

Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies.

McCubrey JA, Abrams SL, Follo MY, Manzoli L, Ratti S, Martelli AM, Cervello M. McCubrey JA, et al. Among authors: martelli am. Adv Biol Regul. 2023 Jan;87:100917. doi: 10.1016/j.jbior.2022.100917. Epub 2022 Sep 29. Adv Biol Regul. 2023. PMID: 36243652

4

Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression.

McCubrey JA, Yang LV, Abrams SL, Steelman LS, Follo MY, Cocco L, Ratti S, Martelli AM, Augello G, Cervello M. McCubrey JA, et al. Among authors: martelli am. Cells. 2022 Jul 9;11(14):2155. doi: 10.3390/cells11142155. Cells. 2022. PMID: 35883598 Free PMC article. Review.

5

Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies.

Martelli AM, Paganelli F, Evangelisti C, Chiarini F, McCubrey JA. Martelli AM, et al. Cells. 2022 May 31;11(11):1812. doi: 10.3390/cells11111812. Cells. 2022. PMID: 35681507 Free PMC article. Review.

6

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.

Lampis S, Raieli S, Montemurro L, Bartolucci D, Amadesi C, Bortolotti S, Angelucci S, Scardovi AL, Nieddu G, Cerisoli L, Paganelli F, Valente S, Fischer M, Martelli AM, Pasquinelli G, Pession A, Hrelia P, Tonelli R. Lampis S, et al. J Exp Clin Cancer Res. 2022 Apr 30;41(1):160. doi: 10.1186/s13046-022-02367-5. J Exp Clin Cancer Res. 2022. PMID: 35490242 Free PMC article.

7

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.

McCubrey JA, Meher AK, Akula SM, Abrams SL, Steelman LS, LaHair MM, Franklin RA, Martelli AM, Ratti S, Cocco L, Barbaro F, Duda P, Gizak A. McCubrey JA, et al. Among authors: martelli am. Aging (Albany NY). 2022 Apr 27;14(8):3365-3386. doi: 10.18632/aging.204038. Epub 2022 Apr 27. Aging (Albany NY). 2022. PMID: 35477123 Free PMC article.

8

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma.

Chiarini F, Paganelli F, Balestra T, Capanni C, Fazio A, Manara MC, Landuzzi L, Petrini S, Evangelisti C, Lollini PL, Martelli AM, Lattanzi G, Scotlandi K. Chiarini F, et al. Among authors: martelli am. Cell Death Dis. 2022 Apr 14;13(4):346. doi: 10.1038/s41419-022-04729-5. Cell Death Dis. 2022. PMID: 35422060 Free PMC article.

9

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.

Abrams SL, Duda P, Akula SM, Steelman LS, Follo ML, Cocco L, Ratti S, Martelli AM, Montalto G, Emma MR, Cervello M, Rakus D, Gizak A, McCubrey JA. Abrams SL, et al. Among authors: martelli am. Cells. 2022 Feb 24;11(5):794. doi: 10.3390/cells11050794. Cells. 2022. PMID: 35269416 Free PMC article.

10

APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.

McCubrey JA, Abrams SL, Steelman LS, Cocco L, Ratti S, Martelli AM, Lombardi P, Gizak A, Duda P. McCubrey JA, et al. Among authors: martelli am. Biomolecules. 2022 Feb 8;12(2):276. doi: 10.3390/biom12020276. Biomolecules. 2022. PMID: 35204775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

229 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year